An integrated wellness team approach to diabetes care can help patients not only improve their condition, but also lower their prescription costs, according to new research presented at the American Association of Clinical Endocrinologists’ 21st annual Scientific and Clinical Congress in Philadelphia.
Faced with the possibility of a critical cutoff in funding for the Food and Drug Administration, Congress moved in late May to reauthorize the Prescription Drug User Fee Act that provides the bulk of the agency’s resources for new-drug review and approval.
The National Association of Chain Drug Stores on Wednesday urged Congress to pass the Prescription Drug User Fee Act, legislation essential to the review process for new medications and that also contains important pro-patient, pro-pharmacy provisions.
Five pharmacy organizations on Thursday wrote Congress in opposition of an amendment to the Food and Drug Administration Safety Innovation Act due to its potential to delay patients' timely relief from chronic pain while increasing drug costs.
An integrated wellness team approach to diabetes care can help patients not only improve their condition, but also lower their prescription costs, according to new research presented at the American Association of Clinical Endocrinologists' 21st annual Scientific and Clinical Congress in Philadelphia.
The battle for public opinion and legislative sway was in full swing Monday as executives from the National Community Pharmacists Association lobbied congressional leaders regarding several pieces of "pro-patient, pro-pharmacist legislation." To counter that effort, the Pharmaceutical Care Management Association issued some marketing firepower of its own.
The Food and Drug Administration's New Dietary Ingredient Draft Guidance should not give the agency pre-market approval over new dietary supplement products, the Council for Responsible Nutrition claimed Monday in a commentary published in Regulatory Toxicology and Pharmacology, the official journal of the International Society of Regulatory Toxicology and Pharmacology.
The Preserve Community Pharmacy Access NOW! coalition — formed in opposition of the proposed Express Scripts-Medco merger — Wednesday afternoon hosted a press conference making a direct appeal to attorneys general to block the ESI-Medco merger in the courts should the Federal Trade Commission approve the merger.
The fourth annual National Association of Chain Drug Stores RxImpact Day on Capitol Hill wrapped up March 22 on a high note. With pharmacists and pharmacy students from around the country able to secure more than 350 meetings with members of the U.S. House and Senate and their staffs last week, most lawmakers who serve on congressional committees with jurisdiction on healthcare issues got to hear pharmacy’s position on prescription reimbursements, fair payment for pharmacy services and the proposed merger of pharmacy benefit management giants Express Scripts and Medco.
The Consumer Healthcare Products Association and the other members of the Health Choices Coalition on Friday sent letters to members of Congress urging the repeal of the requirement that prevents consumers from using their flexible spending arrangements to purchase over-the-counter medicines without first getting a doctor’s prescription.
NACDS RxImpact Day on Capitol Hill showcased the unsurpassed value of community pharmacy as pharmacy advocates from 41 states conducted more than 350 meetings with U.S. senators and representatives this week.
In anticipation of hundreds of meetings between pharmacy advocates and members of Congress and their staff as part of NACDS RxImpact Day on Capitol Hill, the National Association of Chain Drug Stores sent a letter to Rep. Cathy McMorris Rodgers, R-Wash., applauding the introduction of her legislation on Tuesday that would establish Medicare standards for pharmacy audits and reimbursement by pharmacy benefit managers.
In excess of $102 billion. That's the value over-the-counter medicine delivers to the U.S. healthcare system, Consumer Healthcare Products Association leaders shared with attendees of the CHPA Annual Executive Conference held here Friday morning.
Written testimony submitted by the National Association of Chain Drug Stores underscored chain pharmacies’ commitment to patient safety as part of the next Prescription Drug User Fee Act reauthorization, and emphasized that community pharmacist-provided services help improve health outcomes without the introduction of unproven technologies.
Are pharmacists the weak link in the drug diversion chain? That’s what the pharmacy benefit management lobby seems to imply in a new and controversial ad campaign that questions whether community pharmacists are doing all they should to halt the illegal flow of narcotics from the legitimate pharmaceutical supply chain to the dealer on the street.
About $290 billion a year. That’s what Americans’ rampant nonadherence to their prescription medication therapy is costing the country each year in medical bills and lost work, according to national estimates. So getting patients to stick with their drug regimens is a huge challenge, not only for pharmacists in all practice settings, but for the entire healthcare provider network and the U.S. economy.
Message to Congress: You’ve got to spend a little money to save a lot of it. Paying $100 million to the nation’s community pharmacists to provide comprehensive medication therapy management to more American seniors would save Medicare $1 billion or more. Spend $200 million and save $2 billion ... you get the picture.
The call to Congress to reject budget proposals that would increase co-pays for prescription medications at community pharmacies for Tricare patients is important as the war between the pharmacy and pharmacy benefit manager lobbies heats up.
Multibillion-dollar pharmacy benefit management companies are advertising aggressively to try to convince Congress and the Federal Trade Commission to approve a merger between Express Scripts and Medco Health Solutions
The National Association of Chain Drug Stores and the National Community Pharmacists Association are urging Congress to reject budget proposals that would limit pharmacy choice for Tricare beneficiaries.
Multibillion-dollar pharmacy benefit management companies are advertising aggressively to try to convince Congress and the Federal Trade Commission to approve a merger between Express Scripts and Medco Health Solution.